Added to YB: 2024-09-30
Pitch date: 2024-09-30
CORT [bullish]
Corcept Therapeutics Incorporated
+88.9%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Corcept Therapeutics Incorporated engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
Market Cap
$7.9B
Pitch Price
$46.58
Price Target
N/A
Dividend
N/A
EV/EBITDA
106.86
P/E
86.48
EV/Sales
10.02
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Corcept Therapeutics Incorporated. CORT
A summary for this pitch has not been created yet.
Read full article (0 min)